Cerevel Therapeutics Holdings Overview

Cerevel Therapeutics Holdings Other Income Expense Net

Other Income/Expense Net for CERE.

Quarterly Other Income/Expense

-$921000.00

↑ 80.19% YoY

As of Mar 31, 2024

Annual Other Income/Expense (TTM)

$4.23M

↓ 39.11% YoY

Trailing 12 months ending Mar 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin